Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-22

FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide. This action updates the regulatory status of the liraglutide product for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

SUPPL AP for LIRAGLUTIDE (LIRAGLUTIDE)